MED16 and cervical carcinoma: Further candidates in the top 10 were PACS1 (phosphofurin acidic cluster sorting protein 1), which was found to exhibit increased expression in cervical cancer whereas an expression reduction led to reduced proliferation [46], and MED16 (mediator complex subunit 16), which has been shown to promote the proliferation of ER-positive breast cancer [47].